The founder contributed to a new paper in Alzheimer’s & Dementia, entitled ” CSF biomarker variability in the Alzheimer’s Association quality control program”.
Category Archives: validation
2013, 6 April, A new publication on assay validation for integration in clinical trials
The founder was a co-author on a publication in Journal of Alzheimer’s disease entitled “Validation of assays for measurement of Amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer’s disease treated with Solanezumab.”
2012, December – Publication – Validation multiplex Abeta plasma assay
A new paper, entitled “Validation of a multiplex assay for simultaneous quantification of amyloid-beta peptide species in human plasma with utility for measurements in studies of Alzheimer’s Disease Therapeutics” was published in Journal of Alzheimer’s.
